Suginami H
Nihon Naibunpi Gakkai Zasshi. 1975 Nov 20;51(11):908-23. doi: 10.1507/endocrine1927.51.11_908.
Composite microassays for plasma progesterone (P), 17alpha-OH-progesterone (17P), estrone (E1), 17beta-estradiol (E2), and estriol (E3) were developed. Steroids were extracted from plasma samples with diethyl ether, and were separated from each other through two steps of sephadex LH-20 microcolumn chromatography (benzene:methanol 85:15, and n-hexane: benzene: methanol 80:10:10), prior to assays by radioimmunoassay (P, E1, E1, and E3) and competitive protein binding assay (17P). Steroids were recovered satisfactorily through these procedures (mean recovery; P:107.6%, 17P:102.3%, E1:88.2%, E2:84.1%. E3:78.5%). The detectable range for P, 17P, E1, E2, and E3 were 0.01-2 ng/tube, 0.1-10 ng/tube, 10-2000pg/tube, 10-2000 pg/tube, and 0.5-100 ng/tube. The interassay coefficient of variations were less than 10.7%, 15.2%, 17.8%, 11.4%, and 28.1%, respectively. These steroids were measured daily in 4 menstrual cycles from 4 normally menstruating women. Plasma FSH and LH were quantitated previously. The following results were obtained; 1) Plasma P elevated from around LH surge (Day O), and reached a peak on day +5 approximately +7 with the values of 12.74 +/- 2.34 ng/ml (Mean +/- S.D.). 2) Slight decrease in P levels was noted on day +8 approximately +9. 3) A peak in 17P was observed in the preovulatory phase (day -3 approximately -1) with the values of 0.6 approximately 1.3 ng/ml in three of four cases. 4) Changes of 17P during the luteal phase were paralleled to those of P with a peak of 1.16 +/- 0.31 ng/ml on day +5 approximately +7. 5) No remarkable patterns were found in E1 levels throughout the menstrual cycle. 6) A sharp peak in E2 was detected in the preovulatory phase (day -1 approximately 0) with the values of 709.2 +/- 95.9 pg/ml. 7) The second peak of E2 with 378.6 +/- 140.7 pg/ml was observed in the late luteal phase (day +8 approximately +12). 8)E3 was not detected in all samples. The interrelationship between steroids and the correlation with the morphological changes of the ovaries in the normal menstrual cycle are discussed. In the follicular phase, the theca interna cells around the maturing follicle may be growing under the influence of pitiutary gonadotropins to secrete large amounts of 17P and E2, which may possibly affect the pituitary for LH surge, followed by ovulation. In the luteal phase, both the granulosa cells and theca intera cells are luteinized, which may produce and secrete large amount of P, 17P, and E2.
已开发出用于检测血浆孕酮(P)、17α-羟孕酮(17P)、雌酮(E1)、17β-雌二醇(E2)和雌三醇(E3)的复合微量测定法。用乙醚从血浆样本中提取类固醇,在通过放射免疫测定法(检测P、E1、E1和E3)和竞争性蛋白结合测定法(检测17P)进行检测之前,通过两步葡聚糖LH - 20微柱色谱法(苯:甲醇85:15,正己烷:苯:甲醇80:10:10)将它们彼此分离。通过这些程序,类固醇的回收率令人满意(平均回收率;P:107.6%,17P:102.3%,E1:88.2%,E2:84.1%,E3:78.5%)。P、17P、E1、E2和E3的可检测范围分别为0.01 - 2 ng/管、0.1 - 10 ng/管、10 - 2000 pg/管、10 - 2000 pg/管和0.5 - 100 ng/管。批间变异系数分别小于10.7%、15.2%、17.8%、11.4%和28.1%。对4名月经正常的女性在4个月经周期中每日测量这些类固醇。之前已对血浆促卵泡激素(FSH)和促黄体生成素(LH)进行了定量。得到以下结果:1)血浆P在促黄体生成素高峰(第0天)前后升高,并在第 +5天至约 +7天达到峰值,值为12.74±2.34 ng/ml(平均值±标准差)。2)在第 +8天至约 +9天观察到P水平略有下降。3)在排卵前期(第 -3天至约 -1天)观察到17P出现峰值,4例中有3例的值为0.6至约1.3 ng/ml。4)黄体期17P的变化与P的变化平行,在第 +5天至约 +7天达到峰值,为1.16±0.31 ng/ml。5)在整个月经周期中,E1水平未发现明显模式。6)在排卵前期(第 -1天至约0天)检测到E2出现急剧峰值,值为709.2±95.9 pg/ml。7)在黄体后期(第 +8天至约 +12天)观察到E2的第二个峰值,为378.6±140.7 pg/ml。8)所有样本中均未检测到E3。讨论了正常月经周期中类固醇之间的相互关系以及与卵巢形态变化的相关性。在卵泡期,成熟卵泡周围的卵泡内膜细胞可能在垂体促性腺激素的影响下生长,分泌大量的17P和E2,这可能会影响垂体导致促黄体生成素高峰,随后排卵。在黄体期,颗粒细胞和卵泡内膜细胞都发生黄体化,可能产生并分泌大量的P、17P和E2。